A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor ...